Exchange: NASDAQ·Updated 07:53 AM EDT
IPSC logo

IPSC Century Therapeutics Inc

$2.03
$0.06
(2.87%)
Pre-Market
Prev Close $2.09
Reported EarningsAug 12
Mkt Cap$378.45M
Vol65.00

About IPSC

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.
37

Bearish Sentiment

How do you feel about IPSC?

Advertisement|Remove ads.